Consistent with others (35–37), CD11b+CD14+ Mo-MDSC and Lin−HLA-DR−CD11b+CD15+ PMN-MDSC populations were much higher in patients with tumor as compared to tumor free-individuals (Figure 6C). This evidence concerns the gene CD14 and neoplasm.